Innovator IBD® Breakout Opportunities ETF Stock Price, News & Analysis
Company Description
Innovator IBD® Breakout Opportunities ETF (NYSE: BOUT) is a publicly traded company.
BOUT stock has gained 33.9% over the past year. Shares last traded at $46.12.
This page provides a comprehensive overview of BOUT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Innovator IBD® Breakout Opportunities ETF (BOUT) stock last traded at $46.12, up 0.64% from the previous close. Over the past 12 months, the stock has gained 33.9%.
Latest News
Innovator IBD® Breakout Opportunities ETF has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all BOUT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Innovator IBD® Breakout Opportunities ETF (BOUT) currently stands at 408 shares, down 47.3% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 11.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Innovator IBD® Breakout Opportunities ETF (BOUT) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.